PMID: 6798589Nov 1, 1981Paper

Effect of PGE1, PGE2 and PGI2 on ventricular arrhythmias during myocardial infarction in conscious dogs: relation to infarct size

Prostaglandins and Medicine
B I Jugdutt


The relation between the effect of vasodilator prostaglandins on ventricular arrhythmias during myocardial infarction and infarct size was studied in conscious dogs. Two infarct-limiting drugs, nitroglycerin and ibuprofen, were also studied for comparison. Infusions were given between 20 and 380 minutes after occlusion of the left circumflex coronary artery: intravenously for saline (N = 27), ibuprofen (N = 14), and nitroglycerin (N = 14); left atrially for PGE1 (N = 11), PGE2 (N = 12) and PGI2 (N = 18). Doses of prostaglandins and nitroglycerin were adjusted to decrease mean arterial pressure by 5%. Pathologic infarct size was measured 2 days post-occlusion. During the infusion period, ventricular fibrillation (VF) deaths were nil with PGI2 (p less than 0.05) and nitroglycerin (p less than 0.1), ventricular premature beats (VPB's) were less (p less than 0.01) with PGI2, PGE2 and nitroglycerin, and collateral blood flow (microspheres) increased with PGE1, PGI2 and nitroglycerin but did not change with saline, PGE2 and ibuprofen. Infarct size, as percent of left ventricle or occluded bed, was less (p less than 0.05) with PGE1, PGI2, nitroglycerin and ibuprofen but similar with PGE2 and saline. Thus, PGE2 diminished VPB's despite...Continue Reading


Nov 1, 1975·British Heart Journal·R RobertsB E Sobel
Jan 1, 1977·Annual Review of Pharmacology and Toxicology·P Hedqvist
May 18, 1978·The New England Journal of Medicine·P Needleman, G Kaley
Jun 1, 1979·European Journal of Pharmacology·M L OgletreeK C Nicolaou
Dec 1, 1979·Circulation Research·B I JugduttL C Becker
Feb 1, 1978·Circulation Research·M L Ogletree, A M Lefer
Jul 1, 1971·Circulation·B Lown, M Wolf
Mar 1, 1973·The Journal of Physiology·T F McDonald, D P MacLeod
May 1, 1972·European Journal of Pharmacology·W G ZijlstraA J Vergroesen
May 20, 1967·British Medical Journal·P R EmmonsJ R Mitchell
Oct 1, 1967·The American Journal of Cardiology·B LownG Roberge


Nov 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·V B FiedlerR Grützmann
Jan 1, 1991·Basic Research in Cardiology·G R Brodowicz, D R Lamb
Mar 1, 1983·Prostaglandins, Leukotrienes, and Medicine·H J Mest, J Rausch
Sep 1, 1986·Prostaglandins, Leukotrienes, and Medicine·J L VincentJ Van Belle
Apr 1, 1988·Journal of Clinical Pharmacology·E LichsteinO I Linet
Jan 1, 1986·Basic Research in Cardiology·V B Fiedler, M Mardin

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.